Antibody therapeutic prediction and design : immunogenicity and stability
One third of all drugs currently in development are monoclonal antibody therapeutics. Key to the efficacy and safety of therapeutic antibodies is the avoidance of immunogenic reaction upon administration. Immunogenicity describes a patient’s immune response to an antibody therapeutic that leads to p...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University College London (University of London)
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.746395 |